Evidence map›Paper›PMID 29744132›Full record

ArticleConvergent science physical oncology2016

Delayed Onset of Symptoms Through Feedback Interference in Chronic Cancers.

Seth Haney, Tannishtha Reya, Maxim Bazhenov

Open access · bronzeAbstract read
In one paragraph

Article in Convergent science physical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Seth HaneyDepartment of Medicine, University of California, San Diego, La Jolla, CA.
Tannishtha ReyaDepartment of Pharmacology, University of California, San Diego, La Jolla, CA.
Maxim BazhenovDepartment of Medicine, University of California, San Diego, La Jolla, CA.
University of California, San Diego · USSanford Consortium for Regenerative Medicine · US

Funding

Molecular strategies for early detection and targeting of cancerR35CA197699 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Tannishtha Reya · 2015 to 2026
$11.2M
Musashi-mediated control of pancreatic cancer growth and progressionR01CA186043 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LOWY, ANDREW M, REYA, TANNISHTHA · 2015 to 2019
$2.1M
Molecular Determinants of Asymmetric DivisionR01DK099335 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI REYA, TANNISHTHA · 2014 to 2017
$1.5M
NCI NIH HHS R01 CA186043NCI NIH HHS R35 CA197699NIDDK NIH HHS R01 DK099335
6 · The paper itself

Abstract

In many cancers, such as Chronic Myelogenous Leukemia (CML), pancreatic, and colorectal cancer, long delays exist between the initiation of the disease and the onset of debilitating symptoms. The early stages of these diseases present manageable symptoms and, in the case of CML, highly effective treatment options. Progression to the more aggressive stages of the diseases limits effective treatment and significantly exacerbates patient prognosis. The mechanisms causing delay and disease progression are largely unknown. The later stages of these diseases are characterized by excessive build up of primitive cell types, indicating a disruption in the normal cell differentiation process that is commonly regulated through feedback from differentiated types. In this study, we propose a mechanism where mutated primitive cells produce a feedback interference signal that desensitizes them to a normal homeostatic feedback. Using a mathematical model, we show that this mechanism can account for the long delay period between occurrence of genetic changes and symptomatic onset characterized by fast growth of cancerous cell population. Finally, we explore novel concepts for potential treatment of chronic cancers.

Identifiers

PMID29744132
PMCPMC5937283
OpenAlexW2538848034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.